Table 3.
Comparison of treatment in the case of acute facial palsy (≤90 days after onset) versus chronic facial palsy (>90 days after onset).
| Acute Palsy n = 697 |
Chronic Palsy n = 523 |
|||
|---|---|---|---|---|
| Parameter | Absolute (N) | Absolute (N) | Χ2, df | p * |
| Glucocorticoids | 760.0, 1 | <0.0001 | ||
| Yes | 564 | 7 | ||
| No | 133 | 516 | ||
| Acyclovir | 413.5, 1 | <0.0001 | ||
| Yes | 384 | 2 | ||
| No | 313 | 521 | ||
| Antibiotics | 39.9, 1 | <0.0001 | ||
| Yes | 60 | 3 | ||
| No | 637 | 520 | ||
| Facial nerve reconstruction | ||||
| Facial nerve reconstruction, any | 16 | 33 | 14.7, 1 | 0.001 |
| Facial-facial nerve suture | 2 | 2 | 0.01, 1 | 1.000 |
| Facial nerve interpositional graft | 6 | 2 | 1.1, 1 | 0.478 |
| Hypoglossal–facial-nerve jump suture | 10 | 31 | 18.6, 1 | <0.0001 |
| Muscle and sling plasty | ||||
| Temporal muscle transfer | 0 | 1 | 1.3, 1 | 0.429 |
| Sling plasty angle of the mouth | 4 | 12 | 6–8, 1 | 0.011 |
| Eyelid surgery | ||||
| Upper eyelid weight | 31 | 46 | 9.6, 1 | 0.003 |
| Tarsorrhaphy | 1 | 9 | 13.2, 1 | 0.001 |
| Kanthopexy | 3 | 9 | 8.4, 1 | 0.006 |
| Brow plasty | 7 | 15 | 10.8, 1 | 0.002 |
| Blepharoplasty | 2 | 13 | 17.5, 1 | 0.001 |
| Lower lid plasty | 8 | 17 | 12.1, 1 | 0.013 |
| Non-surgical adjuvant therapy | ||||
| Physical therapy/speech therapy | 55 | 47 | 0.5, 1 | 0.531 |
| Electrotherapy | 11 | 47 | 51.5, 1 | <0.0001 |
| Botulinumtoxin injection | 41 | 132 | 92.0, 1 | <0.0001 |
| Eye moisture chamber | 423 | 12 | 444.1, 1 | <0.0001 |
| Eye drops/ointment | 430 | 20 | 430.0, 1 | <0.0001 |
| Facial exercises at home | 441 | 14 | 469.1, 1 | <0.0001 |
| Facial EMG biofeedback training | 31 | 255 | 326.9, 1 | <0.0001 |
* Significant p-values (p < 0.05) in bold; Pearson’s chi-square test.